A recent Finnish study released interim results comparing intermittent androgen deprivation (IAD) to continuous androgen deprivation (CAD) in 856 men. All the men had locally advanced or metastatic prostate cancer and they all were treated at 27 clinics in Finland. The period of study was between 1997 and 2003 and all men were required to [...]
Dendreon Corporation (Nasdaq: DNDN), the company that is testing Provenge a potential vaccine for prostate cancer, has started a second of two new Phase 2 trials. The multicenter trial, called ProACT (PROstate Active Cellular Therapy), is enrolling 120 men with metastatic, androgen independent prostate cancer. The trial protocol calls for all men to receive active [...]
In addition to the three cancers, I also have an arthritic condition. My rheumatologist has prescribed certain medications that require regular monitoring for liver damage, so every six weeks I go into the lab to have a complete blood panel along with my PSA. Included in the blood panel are also some kidney screens. One [...]
I have to admit that cancer researchers are becoming very creative. There is a phase II clinical trial getting ready to start at the Wake Forest University Baptist Medical Center which has a new twist. The treatment is based on injecting white blood cells called 'cancer killing' granulocytes from healthy donors into cancer survivors with [...]
If the thought of eating servings of broccoli and cabbage every day does not appeal to you, then you should read this post to learn why you should grin and bear it. Multiple recent studies continue to document diindolylmethane (DIM) as one of the most effective phytonutrients in the prevention and treatment of breast, prostate, [...]
As new treatments, drugs and medical devices come to market the FDA is charged with making sure that they are both safe and perform as represented. Products that come under review include items such as human and animal drugs, blood and other biological products, medical devices, and foods. The process of evaluating these products has [...]
Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) has announced a new phase I/II clinical trial of Apoptone (HE3235) for late stage prostate cancer. Howard Scher, M.D., Chief of the Genitourinary Oncology Service at Memorial Sloan-Kettering Cancer Center said "The preclinical data generated to date suggest that Apoptone may offer a unique therapeutic approach to late-stage prostate cancer where [...]
Life is tough enough with all of its twists and turns. We all experience hardships on our path, but we all also experience many pleasures and euphoric moments. Those of us who are under the influence of advanced prostate cancer still experience many moments of great pleasure and contentment. As a matter of fact, I [...]
Amgen just completed, with positive results, a three-year Phase 3 placebo-controlled trial which evaluated denosumab for the treatment of bone loss (reduction of bone mineral density –BMD) in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer. One of the more common and significant side effects of ADT is loss of BMD. This loss [...]
Have I been abandoned? I feel as if I have. In today’s mail was a letter from my kidney oncologist (I also have renal cancer) telling me that he will no longer accept my insurance! He said that he hoped that I would continue to use him as my physician, but if not he recommended [...]
